Clinical Trial Update: Topiramate's Effects on Heavy Drinking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topiramate for reducing heavy drinking has been terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol-related Disorders

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Alcohol Drinking | Phase 2 | Status: TERMINATED | Results posted: 2017-12-11